°æºÏ´ëÇб³º´¿ø ¿µ³² ³»°ú°è ½ÅÀåÀÌ½Ä ¿¬±¸È¸ Á¦25Â÷ ÇмúÁý´ãȸ : 2020-03-21 |
|
°æºÏ´ëÇб³º´¿ø ¿µ³² ³»°ú°è ½ÅÀåÀÌ½Ä ¿¬±¸È¸ Á¦25Â÷ ÇмúÁý´ãȸ : 2020-03-21 ±³À°ÀÏÀÚ : 2020-03-21 ±³À°Àå¼Ò : °æºÏ´ëÇб³º´¿ø 10Ãþ ´ë°´ç ±³À°ÁÖÁ¦ : ¿µ³² ³»°ú°è ½ÅÀåÀÌ½Ä ¿¬±¸È¸ Á¦25Â÷ ÇмúÁý´ãȸ ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : ¿µ³²³»°ú°è½ÅÀÌ½Ä ¿¬±¸È¸ ´ã´çÀÚ : Á¤Èñ¿¬ ¿¬¶ôó : 053-200-6328 À̸ÞÀÏ : 83mayring@hanmail.net ±³À°Á¾·ù : ³»°ú Âü¼®¿¹»óÀοø : 90¸í Èñ¸ÁÆòÁ¡ : 3Á¡ Áö¿ª : ´ë±¸±¤¿ª½Ã ±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ ¼¼ºÎ¼ö°·á : 0¿ø ºñ°í ±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ ±³À°½Ã°£ 03-21 ´ë°´ç 15:00~15:25 Next Generation Sequencing in Kidney Transplantation ¿øµ¿ÀÏ(°æºÏ´ëÇб³º´¿ø Áø´Ü°Ë»çÀÇÇаú) ±³À°½Ã°£ 03-21 ´ë°´ç 15:25~15:50 Complement-Mediated Renal Diseases after Kidney Transplantation: Current Diagnostic and Therapeutic Options °¼®ÈÖ(¿µ³²´ëÇб³º´¿ø ½ÅÀå³»°ú) ±³À°½Ã°£ 03-21 ´ë°´ç 15:50~16:15 Kidney Transplantation in HIV-Positive Individuals: Opportunities and Challenges ±èÀÏ¿µ(¾ç»êºÎ»ê´ëÇб³º´¿ø ½ÅÀå³»°ú) ±³À°½Ã°£ 03-21 ´ë°´ç 16:15~16:40 Frailty and Peritransplant Outcomes in Kidney Transplantation ±è±âÅÂ(BHS ÇѼº´¿ø ½ÅÀå³»°ú) ±³À°½Ã°£ 03-21 ´ë°´ç 17:00~17:20 Case 1 Áõ·Ê¹ßÇ¥ÀÚ1() ±³À°½Ã°£ 03-21 ´ë°´ç 17:20~17:40 Case 2 Áõ·Ê¹ßÇ¥ÀÚ2() ±³À°½Ã°£ 03-21 ´ë°´ç 17:40~18:00 Case 3 Áõ·Ê¹ßÇ¥ÀÚ3() ±³À°½Ã°£ 03-21 ´ë°´ç 18:00~18:20 Case 4 Áõ·Ê¹ßÇ¥ÀÚ4() |
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|
Á¦¸ñ |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 361 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 547 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 503 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 354 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 501 , ´ñ±Û¼ö : 0 |